{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:37:43Z","timestamp":1648978663688},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T00:00:00Z","timestamp":1479340800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12916-016-0741-0","type":"journal-article","created":{"date-parts":[[2016,11,14]],"date-time":"2016-11-14T17:45:14Z","timestamp":1479145514000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genomic profiling for copy number changes in plasma of ovarian cancer patients \u2013 a new era for cancer diagnostics?"],"prefix":"10.1186","volume":"14","author":[{"given":"Vathany","family":"Kulasingam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,17]]},"reference":[{"issue":"2","key":"741_CR1","first-page":"266","volume":"1866","author":"F Ren","year":"2016","unstructured":"Ren F, Shen J, Shi H, Hornicek FJ, Kan Q, Duan Z. Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer. Biochim Biophys Acta. 2016;1866(2):266\u201375.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"741_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12916-016-0667-6","volume":"14","author":"PA Cohen","year":"2016","unstructured":"Cohen PA, Flowers N, Tong S, Hannah N, Pertile MD, Hui L. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening. BMC Med. 2016;14(1):126.","journal-title":"BMC Med"},{"key":"741_CR3","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet. 2016;387:945\u201356.","journal-title":"Lancet"},{"key":"741_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1158\/1940-6207.CAPR-10-0195","volume":"4","author":"DW Cramer","year":"2011","unstructured":"Cramer DW, Bast Jr RC, Berg CD, Diamandis EP, Godwin AK, et al. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens. Cancer Prev Res (Phila). 2011;4:365\u201374.","journal-title":"Cancer Prev Res (Phila)"},{"key":"741_CR5","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1038\/521S9a","volume":"521","author":"V Velculescu","year":"2015","unstructured":"Velculescu V, Bender E. Q&A: Victor Velculescu. Out for blood. Nature. 2015;521:S9.","journal-title":"Nature"},{"key":"741_CR6","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1373\/clinchem.2016.260331","volume":"62","author":"F Leung","year":"2016","unstructured":"Leung F, Kulasingam V, Diamandis EP, Hoon DS, Kinzler K, Pantel K, Alix-Panabi\u00e8res C. Circulating tumor DNA as a cancer biomarker: fact or fiction? Clin Chem. 2016;62:1054\u201360.","journal-title":"Clin Chem"},{"key":"741_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1001\/jama.2015.7120","volume":"314","author":"DW Bianchi","year":"2015","unstructured":"Bianchi DW, Chudova D, Sehnert AJ, Bhatt S, Murray K, Prosen TL, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA. 2015;314:162\u20139.","journal-title":"JAMA"},{"key":"741_CR8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jamaoncol.2015.1883","volume":"1","author":"F Amant","year":"2015","unstructured":"Amant F, Verheecke M, Wlodarska I, Dehaspe L, Brady P, Brison N, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015;1:814\u20139.","journal-title":"JAMA Oncol"},{"key":"741_CR9","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/nature10166","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609\u201315.","journal-title":"Nature"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-016-0741-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-016-0741-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T08:48:09Z","timestamp":1487666889000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-016-0741-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,17]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["741"],"URL":"https:\/\/doi.org\/10.1186\/s12916-016-0741-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,17]]},"article-number":"186"}}